Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.

@article{Castells2005CombinedTW,
  title={Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.},
  author={Llu{\'i}s Castells and Victor Vargas and Helena Allende and Itxarone Bilbao and Jos{\'e} Luis L{\'a}zaro and Carlos Margarit and Nancy Roc{\'i}o Rueda Esteban and Jaime De La Guardia},
  journal={Journal of hepatology},
  year={2005},
  volume={43 1},
  pages={
          53-9
        }
}
BACKGROUND/AIMS The efficacy and safety of treatment with pegylated interferon alpha-2b (Peg-Intron, 1.5 microg/kg) and ribavirin (400-800 mg) in the acute phase of recurrent HCV after LT is presented. METHODS Twenty-four patients (17 men) transplanted for HCV-associated cirrhosis (genotype 1b) were treated for at least 6 months and compared with 24 consecutive transplant patients (16 men) without antiviral therapy (controls). RESULTS At completion of treatment, 14/24 treated patients (58… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 48 CITATIONS

Similar Papers

Loading similar papers…